Dempster, Joshua M. https://orcid.org/0000-0002-3634-9576
Pacini, Clare https://orcid.org/0000-0001-7791-0940
Pantel, Sasha
Behan, Fiona M. https://orcid.org/0000-0002-9070-7688
Green, Thomas
Krill-Burger, John https://orcid.org/0000-0001-9614-4671
Beaver, Charlotte M.
Younger, Scott T.
Zhivich, Victor
Najgebauer, Hanna
Allen, Felicity
Gonçalves, Emanuel
Shepherd, Rebecca
Doench, John G. https://orcid.org/0000-0002-3707-9889
Yusa, Kosuke
Vazquez, Francisca https://orcid.org/0000-0002-2857-4685
Parts, Leopold
Boehm, Jesse S. https://orcid.org/0000-0002-6795-6336
Golub, Todd R. https://orcid.org/0000-0003-0113-2403
Hahn, William C. https://orcid.org/0000-0003-2840-9791
Root, David E. https://orcid.org/0000-0001-5122-861X
Garnett, Mathew J.
Tsherniak, Aviad https://orcid.org/0000-0002-3797-1877
Iorio, Francesco https://orcid.org/0000-0001-7063-8913
Funding for this research was provided by:
Wellcome Trust (206194)
Eesti Teadusagentuur (IUT 34-4)
H. L. Snyder Medical Foundation (U01 CA176058, U01 CA199253)
Open Targets: OTAR2-055
Open Targets: OTAR015
Ministry of Education and Research | Estonian Research Competency Council (IUT 34-4)
Article History
Received: 20 June 2019
Accepted: 26 November 2019
First Online: 20 December 2019
Competing interests
: C.P., F.M.B., H.N., M.J.G. and F.I. receive funding from Open Targets, a public-private initiative involving academia and industry. K.Y. and M.J.G. receive funding from AstraZeneca. M.J.G performed consultancy for Sanofi. J.G.D. and A.T. perform consulting for Tango Therapeutics. W.C.H. performs consulting for Thermo Fisher, AdjulB, MBM Capital, and Paraxel, and is a founder and scientific advisory board member of KSQ Therapeutics. T.R.G. performs consulting for GlaxoSmithKline, Sherlock Biosciences, and Foundation Medicine. F.I. performs consultancy for the joint CRUK - AstraZeneca Functional Genomics Centre. All the other authors declare no competing interests.